Interventions to encourage uptake of cancer screening for people with severe mental illness

Authors: Barley, E.A., Borschmann, R.D., Walters, P. and Tylee, A.

Journal: Cochrane Database of Systematic Reviews

Volume: 2016

Issue: 9

eISSN: 1469-493X

DOI: 10.1002/14651858.CD009641.pub3

Abstract:

Background: Adults with severe mental illness (i.e. schizophrenia or other related psychotic disorders and bipolar disorder) can be at greater risk of cancer than those without severe mental illness (SMI). Early detection of cancer through screening is effective in improving patient outcomes including death. However, people with SMI are less likely than others to take up available cancer screening. Objectives: To determine the effectiveness of interventions targeted at adults with SMI, or their carers or health professionals, and aimed at increasing the uptake of cancer screening tests for which the adults with SMI are eligible. Search methods: We searched the Cochrane Schizophrenia Group's Trials Register (October 25, 2012; December 19, 2014; April 07, 2015; July 04, 2016). Selection criteria: All randomised controlled trials (RCTs) of interventions, targeted towards adults with SMI or their carers or health professionals, to encourage uptake of cancer screening tests for which the adults with SMI were eligible. Data collection and analysis: Two review authors independently screened titles and abstracts and assessed these against the inclusion criteria. Main results: We did not find any trials that met the inclusion criteria. Authors' conclusions: A comprehensive search showed that currently there is no RCT evidence for any method of encouraging cancer screening uptake in people with SMI. No specific approach can therefore be recommended. High-quality, large-scale RCTs are needed urgently to help address the disparity between people with SMI and others in cancer screening uptake.

https://eprints.bournemouth.ac.uk/24834/

Source: Scopus

Interventions to encourage uptake of cancer screening for people with severe mental illness.

Authors: Barley, E.A., Borschmann, R.D., Walters, P. and Tylee, A.

Journal: Cochrane Database Syst Rev

Volume: 9

Issue: 9

Pages: CD009641

eISSN: 1469-493X

DOI: 10.1002/14651858.CD009641.pub3

Abstract:

BACKGROUND: Adults with severe mental illness (i.e. schizophrenia or other related psychotic disorders and bipolar disorder) can be at greater risk of cancer than those without severe mental illness (SMI). Early detection of cancer through screening is effective in improving patient outcomes including death. However, people with SMI are less likely than others to take up available cancer screening. OBJECTIVES: To determine the effectiveness of interventions targeted at adults with SMI, or their carers or health professionals, and aimed at increasing the uptake of cancer screening tests for which the adults with SMI are eligible. SEARCH METHODS: We searched the Cochrane Schizophrenia Group's Trials Register (October 25, 2012; December 19, 2014; April 07, 2015; July 04, 2016). SELECTION CRITERIA: All randomised controlled trials (RCTs) of interventions, targeted towards adults with SMI or their carers or health professionals, to encourage uptake of cancer screening tests for which the adults with SMI were eligible. DATA COLLECTION AND ANALYSIS: Two review authors independently screened titles and abstracts and assessed these against the inclusion criteria. MAIN RESULTS: We did not find any trials that met the inclusion criteria. AUTHORS' CONCLUSIONS: A comprehensive search showed that currently there is no RCT evidence for any method of encouraging cancer screening uptake in people with SMI. No specific approach can therefore be recommended. High-quality, large-scale RCTs are needed urgently to help address the disparity between people with SMI and others in cancer screening uptake.

https://eprints.bournemouth.ac.uk/24834/

Source: PubMed

Interventions to encourage uptake of cancer screening for people with severe mental illness

Authors: Barley, E.A., Borschmann, R.D., Walters, P. and Tylee, A.

Journal: COCHRANE DATABASE OF SYSTEMATIC REVIEWS

Issue: 9

eISSN: 1361-6137

ISSN: 1469-493X

DOI: 10.1002/14651858.CD009641.pub3

https://eprints.bournemouth.ac.uk/24834/

Source: Web of Science (Lite)

Interventions to encourage uptake of cancer screening for people with severe mental illness.

Authors: Barley, E.A., Borschmann, R.D., Walters, P. and Tylee, A.

Journal: The Cochrane database of systematic reviews

Volume: 9

Pages: CD009641

eISSN: 1469-493X

ISSN: 1469-493X

DOI: 10.1002/14651858.cd009641.pub3

Abstract:

Background

Adults with severe mental illness (i.e. schizophrenia or other related psychotic disorders and bipolar disorder) can be at greater risk of cancer than those without severe mental illness (SMI). Early detection of cancer through screening is effective in improving patient outcomes including death. However, people with SMI are less likely than others to take up available cancer screening.

Objectives

To determine the effectiveness of interventions targeted at adults with SMI, or their carers or health professionals, and aimed at increasing the uptake of cancer screening tests for which the adults with SMI are eligible.

Search methods

We searched the Cochrane Schizophrenia Group's Trials Register (October 25, 2012; December 19, 2014; April 07, 2015; July 04, 2016).

Selection criteria

All randomised controlled trials (RCTs) of interventions, targeted towards adults with SMI or their carers or health professionals, to encourage uptake of cancer screening tests for which the adults with SMI were eligible.

Data collection and analysis

Two review authors independently screened titles and abstracts and assessed these against the inclusion criteria.

Main results

We did not find any trials that met the inclusion criteria.

Authors' conclusions

A comprehensive search showed that currently there is no RCT evidence for any method of encouraging cancer screening uptake in people with SMI. No specific approach can therefore be recommended. High-quality, large-scale RCTs are needed urgently to help address the disparity between people with SMI and others in cancer screening uptake.

https://eprints.bournemouth.ac.uk/24834/

Source: Europe PubMed Central

Interventions to encourage uptake of cancer screening for people with severe mental illness

Authors: Barley, E.A., Borschmann, R.D., Walters, P. and Tylee, A.

Journal: Cochrane Database of Systematic Reviews

Volume: 2016

Issue: 9

Pages: CD009641

ISSN: 1469-493X

Abstract:

© 2016 The Cochrane Collaboration.Background: Adults with severe mental illness (i.e. schizophrenia or other related psychotic disorders and bipolar disorder) can be at greater risk of cancer than those without severe mental illness (SMI). Early detection of cancer through screening is effective in improving patient outcomes including death. However, people with SMI are less likely than others to take up available cancer screening. Objectives: To determine the effectiveness of interventions targeted at adults with SMI, or their carers or health professionals, and aimed at increasing the uptake of cancer screening tests for which the adults with SMI are eligible. Search methods: We searched the Cochrane Schizophrenia Group's Trials Register (October 25, 2012; December 19, 2014; April 07, 2015; July 04, 2016). Selection criteria: All randomised controlled trials (RCTs) of interventions, targeted towards adults with SMI or their carers or health professionals, to encourage uptake of cancer screening tests for which the adults with SMI were eligible. Data collection and analysis: Two review authors independently screened titles and abstracts and assessed these against the inclusion criteria. Main results: We did not find any trials that met the inclusion criteria. Authors' conclusions: A comprehensive search showed that currently there is no RCT evidence for any method of encouraging cancer screening uptake in people with SMI. No specific approach can therefore be recommended. High-quality, large-scale RCTs are needed urgently to help address the disparity between people with SMI and others in cancer screening uptake.

https://eprints.bournemouth.ac.uk/24834/

Source: BURO EPrints